Biocracked
**Approach:** Human outcome. **Palette:** Natural.

A woman in her fifties, shown from the shoulders down and with her face out of frame, sits at a sunlit wooden kitchen table by a large window. Her hands hold a ceramic mug of black coffee. Beside it lies an open paper notebook with blank pages and a pen. The camera is at eye level with the table and slightly behind her shoulder, with a shallow depth of field that blurs a green garden through the glass. Soft late-morning daylight rakes across her cardigan sleeve, the steam, and the warm grain of the oak. A small green plant leaf in the foreground adds a touch of natural green. The palette is plant greens, honey wood and soft skin tones. The mood is calm and focused, with a hint of a hazy morning, as if a thought is just coming into focus.
Supplements

PQQ, GABA and Caffeine Lifted Menopause Brain Scores. Except One.

Nova Chen · · 4 min read

Menopause brain fog is common, and supplement shelves are full of promises about it. A new randomized trial put one combination to the test, and the result is more interesting than a simple win. A blend of PQQ, GABA, caffeine and B vitamins beat placebo on several cognitive measures. One attention measure went the other way.

Here is what the study found, and what it can't tell you.

The quick version

The trial was published in BMC Nutrition (Kozma, Ratonyi, Takacs et al., 2026). It is open access: https://doi.org/10.1186/s40795-026-01535-6. It is registered at ClinicalTrials.gov as NCT06748989.

  • Who: 63 healthy postmenopausal women completed the study, 30 on the supplement and 33 on placebo.
  • What: A multi-component supplement with PQQ (pyrroloquinoline quinone), GABA, caffeine, vitamins and minerals, versus a matching placebo.
  • How long: 6 weeks.
  • How measured: The CNS Vital Signs computerized neurocognitive battery, taken at baseline and at the end.
  • Design: Randomized 1:1, double-blind, placebo-controlled. Analysis was ANCOVA adjusted for baseline scores.

The headline numbers

The primary endpoint was the Neurocognition Index (NCI), a global score. Compared with placebo, the supplement group improved by an adjusted +5.89 points (95% CI 1.27 to 10.52; p = 0.013).

Several secondary domains also favored the supplement:

  • Memory: +7.86 points (p = 0.020)
  • Visual Memory: +7.97 points (p = 0.030)
  • Cognitive Flexibility: +7.57 points (p = 0.039)
  • Executive Functioning: a favorable trend that just missed significance (p = 0.053)

The researchers concluded that the supplement was associated with better global cognitive performance and selected memory- and executive-related domains.

The plot twist: complex attention

The abstract reports a significant result for Complex Attention that ran in a direction different from the overall pattern. In plain terms, that domain did not follow the improvement seen elsewhere. The abstract does not explain why, and it doesn't give a number I can responsibly quote.

This matters for two reasons. It shows the effect was not a uniform lift across all of cognition. It is also a reminder that when a trial tests many domains, some results will land in unexpected places. That could reflect real effects, such as a stimulant ingredient affecting different tasks differently. It could also be chance. This study can't settle which.

Why these ingredients?

The authors say each ingredient has been individually linked to mechanisms that may support cognitive health. That is a rationale, not proof. This trial tested the blend as one product, so it can't say which ingredient did the work, whether they act together, or whether caffeine alone explains some of the effect. Caffeine is a known stimulant, so that last question is a fair one.

How much to trust it

Treat this as a promising early signal, not a verdict.

  • Small and short. 63 completers over 6 weeks says nothing about long-term effects or brain health down the line. The confidence interval for the main result is wide (1.27 to 10.52), so the true effect could be small or fairly large.
  • Many outcomes. The study looked at multiple cognitive domains. The abstract doesn't mention adjustment for multiple comparisons, so p-values between 0.01 and 0.04 should be read cautiously.
  • A combination product. You can't take these results and assume any single ingredient works alone.
  • Healthy women only. These were healthy postmenopausal participants. The results don't speak to women with diagnosed cognitive impairment, depression, sleep disorders or other conditions.
  • Computerized testing. The CNS Vital Signs battery gives standardized scores, but test scores don't always match how women feel in daily life.
  • Authors' own caveat. They state that larger studies are needed to confirm the findings and assess long-term effects.

I also couldn't check funding or conflicts of interest from the abstract. Read the full open-access paper before drawing conclusions about the product's sponsor.

Practical takeaways

Dose and timing: The abstract does not give per-ingredient doses or dosing schedules, so I won't guess. The only firm detail is that the trial lasted 6 weeks. If you are considering a product, check the full text and the product label, and don't assume a retail supplement matches the trial formula.

Who might be interested: Healthy postmenopausal women curious about cognitive support and willing to treat it as an experiment. That means a defined trial period, a note of how you feel, and realistic expectations.

Who should be cautious or skip it (general safety sense, not findings from this paper):

  • Anyone sensitive to caffeine, or who already struggles with anxiety, palpitations or poor sleep.
  • Anyone taking prescription medications, especially for mood, sleep or anxiety. GABA and caffeine could plausibly matter here, so ask a clinician or pharmacist.
  • Anyone whose attention is the main complaint, given the complex attention result.
  • Anyone whose brain fog is severe, sudden or worsening. That needs a medical evaluation, not a supplement.

Bottom line

In this small, 6-week randomized trial, a PQQ, GABA, caffeine and B-vitamin combination beat placebo on the global Neurocognition Index and on memory, visual memory and cognitive flexibility in healthy postmenopausal women. The complex attention result went the other way, and executive functioning only trended. The trial is encouraging, but it needs larger, longer replication before anyone should treat it as a fix for menopause brain fog.

Source: Kozma B, Ratonyi D, Takacs P, et al. BMC Nutrition, 2026. DOI: 10.1186/s40795-026-01535-6. Trial registration: NCT06748989. This article is for information only and isn't medical advice.

Original study

Read the original research on doi.org →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette C, natural.

A single ceramic cup of freshly brewed green tea sits on a weathered wooden windowsill, photographed from a low three-quarter angle at eye level. Steam curls upward and catches soft, directional morning daylight from a window on the left. The tea is clear amber-green, with a few loose unfurled tea leaves resting on the saucer. Behind the cup, a softly out-of-focus garden of leafy green plants and a bright, hazy sky gives shallow depth of field. The wood has realistic grain and small chips, and the ceramic has a matte, slightly speckled glaze. A single tea leaf in the foreground has a faint electric green tint where light passes through it. The mood is calm, quiet and unhurried, with warm skin-tone wood against cool plant greens. No text, no labels.
supplements

L-Theanine Calms Without Sedation: What Doses Actually Work

BY NOVA CHEN ·

L-theanine, the amino acid in tea, is said to calm you without making you drowsy, and a new Frontiers in Nutrition mini-review tests that claim against human trial evidence. It reports doses of 100-400 mg for small cognitive gains (especially with caffeine), 200-400 mg/day for stress without sedation, and 200-450 mg/day for better sleep quality. The effects are small, and the paper does not report a pooled sample size. Both authors work for a British American Tobacco subsidiary that sells L-theanine products. Here is what the numbers say, who it may suit, and who should skip it.

**Approach: Macro science, with Palette C (natural).**

Extreme close-up, shot from a low 30-degree angle, of finely sifted matcha powder in a shallow matte ceramic bowl. A bamboo whisk's tines have just lifted from the surface, leaving a swirl of vivid green foam with a few tiny bubbles. Individual powder grains and the soft ridges of the foam are sharp in the foreground, and the background falls into a creamy blur. Soft side light from a window at left picks out the velvety texture and a faint sheen on the bubbles. The palette is grassy greens, with a worn wooden table in warm brown and a hint of pale daylight. The mood is calm and focused, with a clean, airy, natural feel. The green is the vivid, near-electric tone of fresh matcha. No text, no logos.
supplements

Matcha Beat Plain Caffeine for Working Under Stress, Study Finds

BY NOVA CHEN ·

Caffeine gets the credit for most of our morning focus, but a randomized placebo-controlled trial in middle-aged and older Japanese adults suggests matcha may offer something extra. A single caffeine dose sharpened attention, yet only continuous daily matcha intake increased work output on a stress-inducing arithmetic test. The authors credit matcha's pairing of caffeine with amino acids like L-theanine. The study has real limits, including mild lab stress, one population and no isolated theanine arm, so the takeaways come with caveats. Here is what the findings mean for matcha versus coffee, daily habits versus one-off doses, and who might benefit.

Approach: the human outcome. Palette: warm, golden-hour light.

A woman in her fifties seen from behind and slightly above, in a low lunge on a yoga mat. Her face is out of frame, and only her shoulders, outstretched arms and tied-back silver-brown hair show. She practices on a wooden floor beside a tall window as low amber sunlight rakes across the room. The light picks out the weave of her rust-colored top and the fine skin texture of her forearms. In the foreground, a small glass dish of deep red-orange astaxanthin softgels sits slightly out of focus on the floor, catching a copper glow. A single small electric green water bottle sits at the edge of the mat. Shot at 35mm with shallow depth of field, in warm honey tones with soft brown shadows. The mood is calm, grounded and quietly hopeful.
supplements

Yoga + Astaxanthin Cut Depression Scores 45%. Alone, Far Less

BY NOVA CHEN ·

A 12-week randomized trial in 100 postmenopausal women found that combining Hatha yoga with 12 mg/day of astaxanthin cut depression scores by 45.1%. Yoga alone managed 28.5%, and astaxanthin alone just 10.9%. The combination also improved menopause symptoms, antioxidant enzyme activity and NRF1 expression, while SIRT1 and PGC-1α rose in both yoga arms. But the study is small, likely single-center and limited to women with mild-to-moderate symptoms. Here's what the numbers show, what they don't, and who the stack might suit.

Approach: conceptual metaphor. Palette: D, bold color field.

A single glass beaker-shaped water pitcher sits on a saturated mustard-yellow seamless backdrop, photographed straight-on at eye level. It is almost empty, with only a thin line of clear liquid at the bottom, standing for drained B12. Beside it, a clean white ceramic head-shaped bust, with no face detail, glows with warm light, as if it were full. A small electric green ribbon is draped over the pitcher handle as the only green accent. Lighting is soft, diffused studio light from the upper left, with gentle, crisp shadows falling to the right on a glossy surface that gives a faint reflection. The mood is curious and paradoxical, a puzzle in which something is depleted yet the outcome looks better. The composition is minimal, with the objects on the right third and generous empty yellow space on the left. Photorealistic, with no text.
longevity

Metformin Drains B12, Yet Diabetic Brains Scored Higher. Why?

BY DR. SYNAPSE ·

Metformin is known to lower vitamin B12, a nutrient your brain depends on. Yet in a new analysis of 587 older adults with type 2 diabetes, metformin users scored higher on a cognitive test, with about 3.5 to 3.75 points more on the DSST after adjustment. B12 and MMA levels didn't statistically explain the difference, with roughly 95% of the association being direct. The benefit appeared concentrated in people aged 60-69 and those with weaker baseline scores. But this is observational, exploratory work in people who already have diabetes, so it can't show that metformin protects the brain.

This page is available in